![]() |
¿¬°£Á¤º¸ ¼ºñ½º
»óǰÄÚµå
1504289
GMIPulse : ÀÇ·á ½ÃÀå ÀÎÅÚ¸®Àü½º ±¸µ¶ ¼ºñ½ºGMIPulse - Healthcare Market Intelligence Subscription |
Global Market Insights Inc.´Â ÃÖ°íÀÇ Àü·«Àû °¡Ä¡¸¦ Á¦°øÇϵµ·Ï ¼³°èµÈ ÃÖ÷´Ü ºñÁî´Ï½º ÀÎÅÚ¸®Àü½º(BI) Ç÷§ÆûÀÎ GMIPulse¸¦ Á¦°øÇϰí ÀÖÀ¸¸ç, GMIPulse´Â Á¾ÇÕÀûÀÌ°í ¼¼ºÐÈµÈ ½ÃÀå µ¥ÀÌÅÍ, °æÀï ȯ°æ ºÐ¼®, »ê¾÷ »ýŰ迡 ´ëÇÑ »ó¼¼ÇÑ Á¤º¸¸¦ Á¦°øÇϸç, °í°´ÀÇ °íÀ¯ÇÑ ´ÏÁî¿¡ ¸Â°Ô ¸ÂÃãÈÇÒ ¼ö ÀÖ´Â ÀûÀÀ·ÂÀÌ ¶Ù¾î³ ±¸µ¶ ¼ºñ½º¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ Ç÷§ÆûÀº ¸ðµç ½ÃÀå Á¶»ç ¿ä±¸ »çÇ×À» ÃæÁ·Çϰí ÃֽŠƮ·»µå¿Í ±â¼ú ¹ßÀü¿¡ ¾Õ¼ ³ª°¥ ¼ö ÀÖµµ·Ï º¸ÀåÇÕ´Ï´Ù.
ÀÇ·á »ê¾÷Àº ±â¼ú ¹ßÀü, ±ÔÁ¦ º¯È, Çõ½ÅÀûÀÎ Ä¡·á ¹× ¼ºñ½º¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ºü¸£°Ô º¯ÈÇϰí ÀÖÀ¸¸ç, GMIPulse´Â ´ÙÀ½°ú °°Àº ÀÇ·á »ê¾÷ÀÇ ÁÖ¿ä ºÎ¹®¿¡ ´ëÇÑ ½ÉÃþÀûÀÎ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù.
ºÐ¼®±â±â ½ÃÀåÀº 2023³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 6.5%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ´Â °í±Þ Áø´Ü µµ±¸ ¹× ¿¬±¸¿ë ¿ëµµ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ÈûÀÔ¾î ¼ºÀåÇÒ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù. ÁÖ¿ä ºÎ¹®À¸·Î´Â Å©·Î¸¶Åä±×·¡ÇÇ, ºÐ±¤ÇÐ, ºÐÀÚ ºÐ¼® µîÀÌ ÀÖ½À´Ï´Ù. Á¤¹ÐÀÇ·á¿Í À¯ÀüüÇÐÀÇ ºÎ»óÀ¸·Î ÀÎÇØ °íÁ¤¹Ð ºÐ¼®±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
»ý¸í°øÇÐ ½ÃÀåÀº À¯Àü°øÇÐ, ¹ÙÀÌ¿À ÀǾàǰ, ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·áÀÇ ¹ßÀü¿¡ ÈûÀÔ¾î 2023³âºÎÅÍ 2030³â±îÁö 7.8%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)·Î °ßÁ¶ÇÑ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÁÖ¿ä ½ÃÀåÀ¸·Î´Â À¯ÀüüÇÐ, ´Ü¹éÁúÇÐ, ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º°¡ ÀÖÀ¸¸ç, CRISPR ±â¼ú°ú °³ÀÎ ¸ÂÃãÇü ÀÇ·áÀÇ ÃâÇöÀÌ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ °ÍÀÔ´Ï´Ù.
¾à¹°-±â±â º¹ÇÕ Á¦Ç° ½ÃÀåÀº ¸¸¼ºÁúȯ À¯º´·ü Áõ°¡¿Í Çõ½ÅÀûÀÎ ¾à¹° Àü´Þ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä¿¡ ÈûÀÔ¾î 2023³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 8.1%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´ëÇ¥ÀûÀÎ ¿¹·Î´Â ¾à¹° ¿ëÃâ ½ºÅÙÆ®, °æÇÇ ÆÐÄ¡, ÈíÀԱ⠵îÀÌ ÀÖ½À´Ï´Ù. ÀǾàǰ°ú ÀÇ·á±â±âÀÇ Á¶ÇÕ¿¡ ½º¸¶Æ® ±â¼úÀ» ÅëÇÕÇÏ¿© ȯÀÚÀÇ ¼øÀÀµµ¿Í Ä¡·á °á°ú¸¦ °³¼±Çϰí ÀÖ½À´Ï´Ù.
ÀÇ·á IT ½ÃÀåÀº ÀüÀÚÀǹ«±â·Ï(EHR), ¿ø°ÝÀÇ·á, ÀÇ·áÁ¤º¸±³È¯(HIE) µµÀÔ Áõ°¡·Î ÀÎÇØ 2023³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 9.4%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÁÖ¿ä ºÐ¾ß·Î´Â ÀÓ»ó Á¤º¸ÇÐ, ÀÇ·á¿ë ºÐ¼®, »çÀ̹ö º¸¾È µîÀÌ ÀÖ½À´Ï´Ù. '°¡Ä¡ ±â¹Ý ÀÇ·á(value-based care)·ÎÀÇ Àüȯ°ú »óÈ£¿î¿ë¼ºÀÇ Çʿ伺ÀÌ ½ÃÀåÀ» ÁÖµµÇÏ´Â Áß¿äÇÑ Æ®·»µåÀÔ´Ï´Ù.
ÀÇ·á±â±â ½ÃÀåÀº ±â¼ú ¹ßÀü°ú °í·ÉÈ Ãß¼¼¿¡ ÈûÀÔ¾î 2023³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 5.9%ÀÇ ¼ºÀå·üÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÁÖ¿ä ºÐ¾ß·Î´Â ¿µ»ó Áø´Ü ±â±â, ¼ö¼ú ±â±â, ¿þ¾î·¯ºí ±â±â µîÀÌ ÀÖÀ¸¸ç, AI ±â¹Ý Áø´Ü µµ±¸, ÃÖ¼Ò Ä§½À ¼ö¼ú ±â±â µîÀÇ Çõ½ÅÀÌ È¯ÀÚ Ä¡·á¿¡ º¯È¸¦ °¡Á®¿À°í ÀÖ½À´Ï´Ù.
ÀÇ·á ¼ºñ½º ½ÃÀåÀº Àü¹® ÀÇ·á ¼ºñ½º ¹× ÀçÅÃÄ¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ÈûÀÔ¾î 2023³âºÎÅÍ 2030³â±îÁö 6.2%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù. ÁÖ¿ä ºÎ¹®À¸·Î´Â ¿ø°Ý ÀÇ·á, ¿Ü·¡ ÀÇ·á, ÀçȰ ¼ºñ½º µîÀÌ ÀÖ½À´Ï´Ù. ¿¹¹æ ÀÇ·á¿Í ¸¸¼º Áúȯ °ü¸®¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼ ÀÇ·á ¼ºñ½º Àü¸ÁÀÌ ÀçÆíµÇ°í ÀÖ½À´Ï´Ù.
ÀǾàǰ ½ÃÀåÀº 2023³âºÎÅÍ 2030³â±îÁö 6.8%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù. Çõ½ÅÀûÀÎ ÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í »ý¹°ÇÐÀû Á¦Á¦ ¹× ¹ÙÀÌ¿À½Ã¹Ð·¯ÀÇ ºÎ»óÀ¸·Î ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ½ÃÀåÀ¸·Î´Â Á¾¾ç, ¸é¿ªÁúȯ, Èñ±ÍÁúȯ µîÀÌ ÀÖ½À´Ï´Ù. »õ·Î¿î Ä¡·á¹ý°ú Á¤¹ÐÀÇ·áÀÇ ¹ßÀüÀº ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä µ¿ÇâÀÔ´Ï´Ù.
GMIPulse´Â BI Áö¿ø Ç÷§ÆûÀ» ÅëÇØ ŸÀÇ ÃßÁ¾À» ºÒÇãÇÏ´Â Àü·«Àû °¡Ä¡¸¦ Á¦°øÇÕ´Ï´Ù. GMIPulse´Â ¸ÂÃãÇü ´ëÈÇü ÀÎÅÍÆäÀ̽º, Á¤È®ÇÑ µ¥ÀÌÅÍ ¹× Á¾ÇÕÀûÀÎ ½ÃÀå °í·Á »çÇ×À» ÅëÇØ °æÀïÀÌ Ä¡¿ÇÑ ÀÇ·á ½ÃÀå¿¡¼ ÇÑ ¹ß ¾Õ¼ ³ª°¥ ¼ö ÀÖ´Â ÇʼöÀûÀÎ µµ±¸ÀÔ´Ï´Ù. ÀÔ´Ï´Ù. Áö±Ý ¹Ù·Î °¡ÀÔÇÏ¿© ½ÃÀå Á¶»ç ¹× Àü·« ¼ö¸³ ´É·ÂÀÇ ÀáÀç·ÂÀ» ±Ø´ëÈÇÒ ¼ö ÀÖ½À´Ï´Ù.
LSH 24.07.23Global Market Insights Inc. offers GMIPulse, a cutting-edge, Business Intelligence (BI)-enabled platform designed to deliver the finest strategic value. GMIPulse offers an adaptable subscription service, customizable to meet your unique needs, providing comprehensive and granular market data, competitive landscape insights, and an in-depth understanding of industry ecosystems. This platform is your go-to solution for all market research needs, ensuring you stay ahead with the latest trends and technological advancements.
The healthcare industry is undergoing rapid transformation driven by technological advancements, regulatory changes, and increasing demand for innovative treatments and services. GMIPulse provides in-depth insights into the following key clusters within the healthcare industry:
The analytical instruments market is projected to grow at a CAGR of 6.5% from 2023 to 2030, driven by the increasing demand for advanced diagnostic tools and research applications. Key segments include chromatography, spectroscopy, and molecular analysis. The rise of precision medicine and genomics is significantly boosting the demand for high-accuracy analytical instruments.
The biotechnology market is anticipated to expand at a robust CAGR of 7.8% from 2023 to 2030, fueled by advancements in genetic engineering, biopharmaceuticals, and cell & gene therapies. Major markets include genomics, proteomics, and bioprocessing. The emergence of CRISPR technology and personalized medicine are key drivers propelling market growth.
The drug device combination market is expected to grow at a CAGR of 8.1% from 2023 to 2030, driven by the increasing prevalence of chronic diseases and the demand for innovative drug delivery systems. Key examples include drug-eluting stents, transdermal patches, and inhalers. The integration of smart technologies in drug-device combinations is enhancing patient compliance and treatment outcomes.
The healthcare IT market is projected to expand at a CAGR of 9.4% from 2023 to 2030, fueled by the increasing adoption of electronic health records (EHR), telemedicine, and health information exchanges (HIE). Key areas include clinical informatics, healthcare analytics, and cybersecurity. The shift towards value-based care and the need for interoperability are significant trends driving the market.
The medical devices market is anticipated to grow at a CAGR of 5.9% from 2023 to 2030, driven by technological advancements and the growing aging population. Major segments include diagnostic imaging, surgical instruments, and wearable devices. Innovations such as AI-powered diagnostic tools and minimally invasive surgical devices are transforming patient care.
The medical services market is expected to expand at a CAGR of 6.2% from 2023 to 2030, supported by the increasing demand for specialized healthcare services and home healthcare. Key segments include telehealth, ambulatory care, and rehabilitation services. The rising focus on preventive care and chronic disease management is reshaping the landscape of medical services.
The pharmaceuticals market is projected to grow at a CAGR of 6.8% from 2023 to 2030, driven by the increasing demand for innovative drugs and the rise of biologics and biosimilars. Key markets include oncology, immunology, and rare diseases. The development of novel therapies and precision medicine are major trends influencing market growth.
GMIPulse by Global Market Insights Inc. offers unparalleled strategic value through its BI-enabled platform. With its customizable and interactive interface, accurate data, and comprehensive market insights, GMIPulse is your essential tool for staying ahead in the competitive healthcare market landscape. Subscribe today to unlock the full potential of your market research and strategic planning capabilities.